Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response. [electronic resource]
Producer: 20060310Description: 300-3 p. digitalISSN:- 0009-9147
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Atorvastatin
- Cyclooxygenase 2 -- biosynthesis
- Female
- Heptanoic Acids -- administration & dosage
- Humans
- Leukocytes, Mononuclear -- drug effects
- Male
- Middle Aged
- Myocardial Infarction -- blood
- Protein C -- metabolism
- Pyrroles -- administration & dosage
- RNA, Messenger -- biosynthesis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.